KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
56 hedge funds and large institutions have $222M invested in Kindred Biosciences, Inc. in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
56
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14.9M | |
| 2 | +$11.2M | |
| 3 | +$6.99M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$3.82M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$3.26M |
Top Sellers
| 1 | -$1.82M | |
| 2 | -$339K | |
| 3 | -$244K | |
| 4 |
PP
PDT Partners
New York
|
-$217K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$155K |